
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $75.6B | $104.7B | $105.9B | $92.3B | $96.3B | |
Revenue Growth (YoY) | -3.2% | 38.6% | 1.16% | -12.84% | 4.25% | |
Cost of Revenues | $67.9B | $94.6B | $95.6B | $83.2B | $87.8B | |
Gross Profit | $7.7B | $10.2B | $10.3B | $9.1B | $8.5B | |
Gross Profit Margin | 10.13% | 9.71% | 9.76% | 9.9% | 8.79% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.7B | $5.3B | $5.2B | $5.5B | $5.8B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $5.7B | $5.3B | $5.2B | $5.5B | $5.8B | |
Operating Income | $1.9B | $4.9B | $5.1B | $3.6B | $2.6B | |
Net Interest Expenses | $302.5M | $243.4M | $494.9M | $719.1M | $748.6M | |
EBT. Incl. Unusual Items | $4.2B | $10.4B | $10.3B | $9B | $7.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $941.6M | $2B | $1.8B | $1.5B | $1.4B | |
Net Income to Company | $3.3B | $8.4B | $8.6B | $7.5B | $6.1B | |
Minority Interest in Earnings | -$140.8M | -$204.4M | -$177.7M | -$116.4M | -$139.3M | |
Net Income to Common Excl Extra Items | $3.2B | $8.1B | $8.4B | $7.4B | $5.9B | |
Basic EPS (Cont. Ops) | $18.80 | $50.03 | $53.46 | $48.90 | $40.28 | |
Diluted EPS (Cont. Ops) | $18.79 | $50.01 | $53.42 | $48.87 | $40.24 | |
Weighted Average Basic Share | $168.3M | $162.9M | $156.6M | $150.7M | $146.8M | |
Weighted Average Diluted Share | $168.4M | $162.9M | $156.7M | $150.8M | $146.9M | |
EBITDA | $7.3B | $13.4B | $13.2B | $12.2B | $10.9B | |
EBIT | $4.7B | $10.8B | $11.2B | $10.2B | $8.8B | |
Revenue (Reported) | $75.6B | $104.7B | $105.9B | $92.3B | $96.3B | |
Operating Income (Reported) | $1.9B | $4.9B | $5.1B | $3.6B | $2.6B | |
Operating Income (Adjusted) | $4.7B | $10.8B | $11.2B | $10.2B | $8.8B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $19.5B | $27.9B | $25.6B | $24.5B | $23.9B | |
Revenue Growth (YoY) | 18.88% | 43.23% | -8.2% | -4.3% | 4.31% | |
Cost of Revenues | $17.6B | $25.6B | $22.9B | $22B | $21.8B | |
Gross Profit | $1.9B | $2.3B | $2.7B | $2.5B | $2.2B | |
Gross Profit Margin | 9.84% | 8.27% | 10.69% | 10.38% | 9.12% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.6B | $1.3B | $1.3B | $1.3B | $1.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.6B | $1.3B | $1.3B | $1.3B | $1.4B | |
Operating Income | $338.1M | $1B | $1.4B | $1.2B | $757.5M | |
Net Interest Expenses | $80.4M | $42.5M | $135.1M | $170M | $215.4M | |
EBT. Incl. Unusual Items | $841.8M | $2.6B | $2.7B | $2.3B | $2B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$41.9M | $515.7M | $501.5M | $445.2M | $343M | |
Net Income to Company | $901.5M | $1.9B | $2.1B | $1.8B | -- | |
Minority Interest in Earnings | -$32.4M | -$37.8M | -$32.8M | -$25.6M | -$34.1M | |
Net Income to Common Excl Extra Items | $851.3M | $2B | $2.1B | $1.8B | $1.6B | |
Basic EPS (Cont. Ops) | $5.07 | $12.42 | $13.74 | $12.17 | $10.79 | |
Diluted EPS (Cont. Ops) | $5.07 | $12.41 | $13.74 | $12.16 | $10.78 | |
Weighted Average Basic Share | $167.9M | $161.9M | $155.7M | $150.4M | $145.8M | |
Weighted Average Diluted Share | $168M | $162M | $155.8M | $150.5M | $146M | |
EBITDA | $1.6B | $3.3B | $3.4B | $3.1B | $2.8B | |
EBIT | $962.6M | $2.7B | $2.9B | $2.6B | $2.3B | |
Revenue (Reported) | $19.5B | $27.9B | $25.6B | $24.5B | $23.9B | |
Operating Income (Reported) | $338.1M | $1B | $1.4B | $1.2B | $757.5M | |
Operating Income (Adjusted) | $962.6M | $2.7B | $2.9B | $2.6B | $2.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $75.6B | $104.5B | $105.9B | $92.2B | $97.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $67.9B | $94.4B | $95.6B | $83.1B | $88.9B | |
Gross Profit | $7.7B | $10.1B | $10.3B | $9.1B | $8.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.7B | $5.3B | $5.2B | $5.5B | $5.9B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $5.7B | $5.3B | $5.2B | $5.5B | $5.9B | |
Operating Income | $1.9B | $4.8B | $5.1B | $3.6B | $2.7B | |
Net Interest Expenses | $302.4M | $244.4M | $494.2M | $716.9M | $757.1M | |
EBT. Incl. Unusual Items | $4.2B | $10.3B | $10.3B | $9B | $7.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $936M | $2B | $1.8B | $1.5B | $1.4B | |
Net Income to Company | $3.3B | $8.4B | $8.6B | $7.5B | -- | |
Minority Interest in Earnings | -$140.7M | -$204.9M | -$180.2M | -$117.8M | -$140.7M | |
Net Income to Common Excl Extra Items | $3.2B | $8.1B | $8.4B | $7.4B | $6B | |
Basic EPS (Cont. Ops) | $18.83 | $49.88 | $53.44 | $48.78 | $40.71 | |
Diluted EPS (Cont. Ops) | $18.82 | $49.86 | $53.41 | $48.74 | $40.68 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $7.3B | $13.4B | $13.2B | $12.2B | $11B | |
EBIT | $4.7B | $10.8B | $11.2B | $10.2B | $8.9B | |
Revenue (Reported) | $75.6B | $104.5B | $105.9B | $92.2B | $97.4B | |
Operating Income (Reported) | $1.9B | $4.8B | $5.1B | $3.6B | $2.7B | |
Operating Income (Adjusted) | $4.7B | $10.8B | $11.2B | $10.2B | $8.9B |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Revenue | $77.3B | $81.1B | $69.8B | $48.6B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $70.1B | $73.7B | $63B | $44.3B | -- | |
Gross Profit | $7.1B | $7.5B | $6.9B | $4.3B | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.8B | $3.8B | $4.1B | $2.7B | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $3.8B | $3.8B | $4.1B | $2.7B | -- | |
Operating Income | $3.3B | $3.7B | $2.8B | $1.6B | -- | |
Net Interest Expenses | $191.4M | $295.6M | $498.8M | $402.4M | -- | |
EBT. Incl. Unusual Items | $7.5B | $7.8B | $6.5B | $4.2B | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6B | $1.5B | $1.3B | $762.1M | -- | |
Net Income to Company | $5.7B | $6.1B | $5B | -- | -- | |
Minority Interest in Earnings | -$155.3M | -$161.8M | -$117.9M | -$74.1M | -- | |
Net Income to Common Excl Extra Items | $5.7B | $6.2B | $5.1B | $3.3B | -- | |
Basic EPS (Cont. Ops) | $34.87 | $39.16 | $33.64 | $22.65 | -- | |
Diluted EPS (Cont. Ops) | $34.85 | $39.14 | $33.61 | $22.63 | -- | |
Weighted Average Basic Share | $490.5M | $473.1M | $453.1M | $295.2M | -- | |
Weighted Average Diluted Share | $490.7M | $473.3M | $453.4M | $295.4M | -- | |
EBITDA | $9.8B | $9.9B | $8.8B | $5.8B | -- | |
EBIT | $7.8B | $8.4B | $7.4B | $4.8B | -- | |
Revenue (Reported) | $77.3B | $81.1B | $69.8B | $48.6B | -- | |
Operating Income (Reported) | $3.3B | $3.7B | $2.8B | $1.6B | -- | |
Operating Income (Adjusted) | $7.8B | $8.4B | $7.4B | $4.8B | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $9.6B | $9.2B | $10.4B | $5.9B | $6.5B | |
Short Term Investments | $3.9B | $8.2B | $5.8B | $7.5B | $6.3B | |
Accounts Receivable, Net | $16.4B | $18.9B | $16.4B | $14.6B | $14.9B | |
Inventory | $5.6B | $7.8B | $7.1B | $6.4B | $6.4B | |
Prepaid Expenses | $1.3B | $1.5B | $1.7B | $2.4B | $2.9B | |
Other Current Assets | $1.3B | $1.3B | $862.4M | $857.7M | $873.2M | |
Total Current Assets | $38.1B | $46.8B | $42.6B | $38.1B | $38B | |
Property Plant And Equipment | $19.7B | $18B | $17.3B | $15.9B | $16.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $1B | $989.3M | $1.1B | $1.3B | $995.8M | |
Total Assets | $113.5B | $122.3B | $115.4B | $111.7B | $112.4B | |
Accounts Payable | $11.9B | $14.2B | $11.3B | $10.9B | $11.2B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $417.2M | $451.5M | $358.8M | $364.4M | $383M | |
Total Current Liabilities | $24.5B | $31.2B | $28.3B | $25.7B | $24.4B | |
Long-Term Debt | $36.2B | $34.3B | $28.5B | $25.2B | $27.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $69.7B | $74.8B | $66.2B | $60.3B | $60.5B | |
Common Stock | $3.1B | $2.8B | $2.6B | $2.3B | $2.3B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $41.4B | $45.9B | $47.8B | $49.8B | $50.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.3B | $1.6B | $1.5B | $1.5B | $1.4B | |
Total Equity | $43.7B | $47.5B | $49.3B | $51.3B | $51.9B | |
Total Liabilities and Equity | $113.5B | $122.3B | $115.4B | $111.7B | $112.4B | |
Cash and Short Terms | $13.5B | $17.4B | $16.2B | $13.5B | $12.8B | |
Total Debt | $43B | $40B | $37.8B | $31.6B | $32.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $9.6B | $9.2B | $10.4B | $5.9B | $6.5B | |
Short Term Investments | $3.9B | $8.2B | $5.8B | $7.5B | $6.3B | |
Accounts Receivable, Net | $16.4B | $18.9B | $16.4B | $14.6B | $14.9B | |
Inventory | $5.6B | $7.8B | $7.1B | $6.4B | $6.4B | |
Prepaid Expenses | $1.3B | $1.5B | $1.7B | $2.4B | $2.9B | |
Other Current Assets | $1.3B | $1.3B | $862.4M | $857.7M | $873.2M | |
Total Current Assets | $38.1B | $46.8B | $42.6B | $38.1B | $38B | |
Property Plant And Equipment | $19.7B | $18B | $17.3B | $15.9B | $16.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $1B | $989.3M | $1.1B | $1.3B | $995.8M | |
Total Assets | $113.5B | $122.3B | $115.4B | $111.7B | $112.4B | |
Accounts Payable | $11.9B | $14.2B | $11.3B | $10.9B | $11.2B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $417.2M | $451.5M | $358.8M | $364.4M | $383M | |
Total Current Liabilities | $24.5B | $31.2B | $28.3B | $25.7B | $24.4B | |
Long-Term Debt | $36.2B | $34.3B | $28.5B | $25.2B | $27.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $69.7B | $74.8B | $66.2B | $60.3B | $60.5B | |
Common Stock | $3.1B | $2.8B | $2.6B | $2.3B | $2.3B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.3B | $1.6B | $1.5B | $1.5B | $1.4B | |
Total Equity | $43.7B | $47.5B | $49.3B | $51.3B | $51.9B | |
Total Liabilities and Equity | $113.5B | $122.3B | $115.4B | $111.7B | $112.4B | |
Cash and Short Terms | $13.5B | $17.4B | $16.2B | $13.5B | $12.8B | |
Total Debt | $43B | $40B | $37.8B | $31.6B | $32.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $3.3B | $8.4B | $8.6B | $7.5B | $6.1B | |
Depreciation & Amoritzation | $2.6B | $2.6B | $2B | $2B | $2.1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$384.9M | -$3.7B | $1.6B | -$257.3M | -$667.8M | |
Change in Inventories | -$321.8M | -$2.6B | $397.7M | $373.6M | $37.9M | |
Cash From Operations | $7.3B | $7.2B | $7.8B | $6B | $6.7B | |
Capital Expenditures | $2B | $1.7B | $1.4B | $2B | $2.3B | |
Cash Acquisitions | -$533.1M | -$241.1M | -$765.9M | -$1.8B | -$536.9M | |
Cash From Investing | -$3B | -$1.6B | -$1.3B | -$3B | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$1.3B | -$1.3B | -$1.5B | -$1.7B | -$1.8B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $8.1B | $10.7B | -- | $6B | $9.7B | |
Long-Term Debt Repaid | -$9.8B | -$11.2B | -$1.6B | -$8.3B | -$8.8B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$171.8M | -$873.6M | -$384.6M | -$72.9M | -$197.7M | |
Cash From Financing | -$4.6B | -$5.5B | -$4.7B | -$7B | -$4.9B | |
Beginning Cash (CF) | $10B | $9.5B | $8.4B | $9.6B | $5.9B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$346.6M | $101.4M | $1.7B | -$4B | $695.4M | |
Ending Cash (CF) | $10B | $10B | $10.3B | $6.2B | $6.4B | |
Levered Free Cash Flow | $5.3B | $5.5B | $6.4B | $3.9B | $4.4B |
Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $488.9M | $1.3B | $2.6B | $2.4B | $2.5B | |
Depreciation & Amoritzation | $651.6M | $664.1M | $660.5M | $555.9M | $619.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $1.2B | -$502.4M | $629.8M | $1.7B | $1.1B | |
Change in Inventories | $1.1B | $103.2M | -$414M | $654.6M | -$108.1M | |
Cash From Operations | $1.3B | $2.5B | $4B | $3.5B | $1.4B | |
Capital Expenditures | $699.8M | $341.5M | $407.8M | $162.3M | $441.6M | |
Cash Acquisitions | $708.4M | -$56M | $20.8M | -$204.8M | -$496.3M | |
Cash From Investing | $193.6M | -$87.8M | $60.8M | -$424.1M | -$769.7M | |
Dividends Paid (Ex Special Dividend) | -$609.5K | $19.2M | -$16.4M | -$61.9M | -$38.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2B | $1.6B | $3.5B | -$6.1B | $946.7M | |
Long-Term Debt Repaid | -$726.7M | -$3.2B | -$3.8B | $4.5B | -$1.6B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$51.5M | -$52.5M | -$664.8M | -$95.1M | -$44.8M | |
Cash From Financing | -$136.7M | -$1.9B | -$2B | -$2B | -$2.4B | |
Beginning Cash (CF) | $8.7B | -- | $7.4B | $8.8B | $7.6B | |
Foreign Exchange Rate Adjustment | -$306.8M | $310M | $414.5M | $48.7M | $240.9M | |
Additions / Reductions | $1.3B | $499.7M | $2.1B | $1.1B | -$1.8B | |
Ending Cash (CF) | $9.7B | $10B | $10B | $10.3B | $6.2B | |
Levered Free Cash Flow | $585.5M | $2.1B | $3.6B | $3.3B | $932.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.5B | $7B | $8.7B | $7.5B | -- | |
Depreciation & Amoritzation | $2.6B | $2.6B | $2.1B | $2B | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $1.3B | -$4.8B | $506M | $337.4M | -- | |
Change in Inventories | $691.1M | -$2.1B | -$670.8M | $1.1B | -- | |
Cash From Operations | $6.1B | $5.6B | $8.3B | $8.1B | -- | |
Capital Expenditures | $2.4B | $1.6B | $1.7B | $1.7B | $1.5B | |
Cash Acquisitions | $231.2M | -$317.9M | -$540.3M | -$1.5B | -$1.3B | |
Cash From Investing | -$2.8B | -$1.8B | -$835.8M | -$2.6B | -- | |
Dividends Paid (Ex Special Dividend) | -$1.3B | -$1.3B | -$1.4B | -$1.7B | -$846.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $8.5B | $8.9B | $9.6B | -$1.1B | -- | |
Long-Term Debt Repaid | -$7.4B | -$10.6B | -$9.9B | -$2.3B | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$170.7M | -$261.4M | -$954.3M | -$123.2M | -- | |
Cash From Financing | -$2.8B | -$5.4B | -$4.7B | -$6.6B | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $495.9M | -$1.5B | $2.8B | -$1.1B | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $3.7B | $4.1B | $6.6B | $6.5B | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.